Performance of Dairy Goats to Alfalfa Silage Based Diets Supplemented with Different Sources of Carbohydrates

Lactating Saanen dairy goats fed alfalfa silage (AS) based diets in four 4x4 Latin Square designed experiment were studied for the effects of supplementation of three different type of carbohydrates (wheat grain, (W); sorghum grain, (SG) and dry citrus pulp, (DCP)) on milk yield, composition and chewing activities. Sixteen does (45± 10 DIM and 2.016 kg ± 0.48 4% FCM) housed indoors in individual pens in a four 4x4 experiment were fed four diets 1) AS (33.9%DM, 19.9%CP, 44.01%NDF); 2) ASW (52.4%DM, 19.8%CP, 33.7%NDF); 3) ASSG (50.9%DM, 17.9%CP, 37%NDF), 4) ASDCP (52.5%DM, 16.12%CP, 39.1%NDF) with forage-to-concentrate ratios of 100:0 or 65:35, 67:33 and 64:36 respectively. Intake of AS DM (2.78%BW) was different (P\u3c 0.05) from the other treatments (average 3.53 ±0.07 %BW). Chewing efficiency (min/g NDF per kg BW 0.75) decrease (P\u3c 0.05) as a result of AS substitution or concentrate supplementation without effect (P\u3e 0.05) of carbohydrate type or dietary level of NDF. Milk, 4%FCM and fat-protein-corrected milk yield was affected (P\u3c 0.05) by concentrate supplementation. Either milk protein content (g/l) or yield (g/day) were not affected by treatments. Body weight changes appeared related to concentrate supplementation. Supplementation increase total DM intake, decrease forage DM intake and chewing efficiency and increase producing performance without changing milk composition

Late Endocrine and Metabolic Sequelae and Long‐Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B‐Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi

Background: Overall survival after lymphoma has improved in recent years, but the high prevalence of late treatment‐related sequelae has been observed as a counterpart. Method: In this systematic review, FIL researchers aimed to: (i) estimate the incidence or prevalence of late endocrine‐metabolic sequelae, (ii) evaluate the effects of modern therapeutic approaches on incidence or prevalence of late endocrine‐metabolic sequelae, and (iii) determine whether there is evidence of follow‐up schemes for their screening/early diagnosis in the subset of long‐term classical Hodgkin lymphoma (cHL) and diffuse large B‐cell lymphoma (DLBCL) survivors treated at adult age. The MEDLINE, Embase and the Cochrane Library databases were searched for relevant articles published up to October, 2020. The study selection process was conducted by three independent reviewers and was reported according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A risk of bias assessment was performed using the Cochrane tool for randomized trials and the Newcastle‐Ottawa Scale for observational studies. Results: In the final analysis, eight studies were included, four of which focused on thyroid disease, two on gonadal dysfunction, one on bone disease and one on metabolic syndrome. Hypothyroidism was reported in up to 60% of adult cHL survivors and was frequently recorded even with modern radiotherapy approaches. Menopause occurred in 52–72% of women after chemotherapy. An 86% reduction in vertebral density was reported following R‐CHOP‐like chemotherapy. Sarcopenia and metabolic syndrome were reported in 37.9% and 60% of patients, respectively. No validated screening protocols were found for the early diagnosis of long‐term treatment‐related endocrine and metabolic sequelae, thus the authors finally suggest the execution of screening exams according to the risk category which were identified in the epidemiologic studies

Structural characterization of the Xi class glutathione transferase from the haloalkaliphilic archaeon Natrialba magadii

Xi class glutathione transferases (GSTs) are a recently identified group, within this large superfamily of enzymes, specifically endowed with glutathione-dependent reductase activity on glutathionyl-hydroquinone. Enzymes belonging to this group are widely distributed in bacteria, fungi, and plants but not in higher eukaryotes. Xi class GSTs are also frequently found in archaea and here we focus on the enzyme produced by the extreme haloalkaliphilic archaeon Natrialba magadii (NmGHR). We investigated its function and stability and determined its 3D structure in the apo form by X-ray crystallography. NmGHR displays the same fold of its mesophilic counterparts, is enriched in negatively charged residues, which are evenly distributed along the surface of the protein, and is characterized by a peculiar distribution of hydrophobic residues. A distinctive feature of haloalkaliphilic archaea is their preference for γ-glutamyl-cysteine over glutathione as a reducing thiol. Indeed we found that the N. magadii genome lacks a gene coding for glutathione synthase. Analysis of NmGHR structure suggests that the thiol binding site (G-site) of the enzyme is well suited for hosting γ-glutamyl-cysteine

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma

Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have a long life expectancy when in complete remission at the end of first, or sometimes second, line treatments [...]

The impact of nitric oxide toxicity on the evolution of the glutathione transferase superfamily: A proposal for an evolutionary driving force

Background: Why do ancestral GSTs utilize cysteine/serine as catalytic residues, whereas more recently evolved GSTs utilize tyrosine? Results: Only the more recently evolved GSTs display enough affinity to bind and make harmless the toxic DNDGIC (a natur

Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications

Background: Prevalence rates of patients with diabetes are growing across countries, and Bangladesh is no exception. Associated costs are also increasing, driven by costs associated with the complications of diabetes including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia as well as improve patient comfort and adherence. However, they have been appreciably more expensive reducing their affordability and use. Biosimilars offer a way forward. Consequently, there is a need to document current prescribing and dispensing rates for long-acting insulin analogues across Bangladesh, including current prices and differences, as a result of affordability and other issues. Methods: Mixed method approach including surveying prescribing practices in hospitals coupled with dispensing practices and prices among community pharmacies and drug stores across Bangladesh. This method was adopted since public hospitals only dispense insulins such as soluble insulins free-of-charge until funds run out and all long-acting insulin analogues have to be purchased from community stores. Results: There has been growing prescribing and dispensing of long-acting insulins in Bangladesh in recent years, accounting for over 80% of all insulins dispensed in a minority of stores. This has been helped by growing prescribing and dispensing of biosimilar insulin glargine at lower costs that the originator, with this trend likely to continue with envisaged growth in the number of patients. Consequently, Bangladesh can serve as an exemplar to other low- and middle-income countries struggling to fund long-acting insulins for their patients. Conclusions: It was encouraging to see continued growth in the prescribing and dispensing of long-acting insulin analogues in Bangladesh via the increasing availability of biosimilars. This is likely to continue benefitting all key stakeholder groups